Prophylaxis for venous thromboembolism after resection of hepatocellular carcinoma on cirrhosis: Is it necessary?

World Journal of Gastroenterology

Volumn 16, Issue 17, 2010, Pages 2146-2150

  Vivarelli, Marco ^a   Zanello, Matteo ^a   Zanfi, Chiara ^a   Cucchetti, Alessandro ^a   Ravaioli, Matteo ^a   del Gaudio, Massimo ^a   Cescon, Matteo ^a   Lauro, Augusto ^a   Montanari, Eva ^b   Grazi, Gian Luca ^a   Pinna, Antonio Daniele ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Hepatic surgery; Hepatocellular carcinoma; Liver cirrhosis; Postoperative bleeding; Postoperative thromboembolism; Venous thromboembolism prophylaxis

Indexed keywords

ENOXAPARIN; FRESH FROZEN PLASMA; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN;

ADULT; AGE; AGED; ARTICLE; BLOOD TRANSFUSION; BODY MASS; CANCER SURGERY; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE MODEL; DRUG EFFICACY; DRUG SAFETY; ESOPHAGUS VARICES; FEMALE; GENDER; HEMOPERITONEUM; HUMAN; INCIDENCE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OPERATION DURATION; STOMACH HEMORRHAGE; SURGICAL TECHNIQUE; THROMBOCYTE COUNT; THROMBOSIS PREVENTION; VENOUS THROMBOEMBOLISM;

EID: 77952504866     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i17.2146     Document Type: Article

References (12)

1. National Institute for Health and Clinical Excellence (NICE) Clinical Guidelines. CG 46 Full Guidance 2007. Venous Thromboembolism. Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism in patients undergoing surgery). Available from: URL: http://www.nice.org.uk/guidance
2. Leonardi MJ, McGory ML, Ko CY. A systematic review of deep venous thrombosis prophylaxis in cancer patients: implications for improving quality. Ann Surg Oncol 2007; 14: 929-936
3. Martin P. Hepatocellular carcinoma: risk factors and natural history. Liver Transpl Surg 1998; 4: S87-S91
4. Lisman T, Leebeek FW. Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment. Dig Surg 2007; 24: 250-258
5. Nagasue N, Kohno H, Chang YC, Taniura H, Yamanoi A, Uchida M, Kimoto T, Takemoto Y, Nakamura T, Yukaya H. Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years. Ann Surg 1993; 217: 375-384
6. Northup PG, Sundaram V, Fallon MB, Reddy KR, Balogun RA, Sanyal AJ, Anstee QM, Hoffman MR, Ikura Y, Caldwell SH. Hypercoagulation and thrombophilia in liver disease. J Thromb Haemost 2008; 6: 2-9
7. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-649
8. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864-871
9. Vermaas AM. Liability in relation to the use of professional medical guidelines. Med Law 2003; 22: 233-238
10. Belghiti J, Hiramatsu K, Benoist S, Massault P, Sauvanet A, Farges O. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 2000; 191: 38-46
11. Taketomi A, Kitagawa D, Itoh S, Harimoto N, Yamashita Y, Gion T, Shirabe K, Shimada M, Maehara Y. Trends in morbidity and mortality after hepatic resection for hepatocellular carcinoma: an institute's experience with 625 patients. J Am Coll Surg 2007; 204: 580-587
12. Tripodi A, Caldwell SH, Hoffman M, Trotter JF, Sanyal AJ. Review article: the prothrombin time test as a measure of bleeding risk and prognosis in liver disease. Aliment Pharmacol Ther 2007; 26: 141-148